As biotech mar­ket re­mains chilly, Longeveron CEO steps down af­ter 18-month run

The Longeveron CEO who helped take the biotech pub­lic is now set to re­sign.

Ge­off Green, Longeveron’s chief ex­ec­u­tive since No­vem­ber 2020, will step down ef­fec­tive June 1 to pur­sue new op­por­tu­ni­ties, the com­pa­ny an­nounced Mon­day af­ter­noon. In his place, cur­rent CMO Chris Min will serve as in­ter­im CEO while Longeveron con­ducts a search for a per­ma­nent chief.

Green will re­main a con­sul­tant for an un­de­ter­mined time to help en­sure a smooth tran­si­tion, the com­pa­ny added. Shares $LGVN were down about 5% in post-mar­ket trad­ing. He joins a cadre of biotech ex­ec­u­tives leav­ing their posts in the wake of a bear mar­ket that con­tin­ues to bat­ter the sec­tor.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER